EP300 and acute myeloid leukemia: The antibiotic polyether monensin was described as a MYB inhibitor with antiproliferative activity against AML and ACC cells, but the inhibition of the MYB-p300 interaction by monensin occurred indirectly and not by targeting MYB-KIX[231].